ES2252509T3 - Compuestos de aminopirrol como agentes antiinflamatorios. - Google Patents

Compuestos de aminopirrol como agentes antiinflamatorios.

Info

Publication number
ES2252509T3
ES2252509T3 ES02767427T ES02767427T ES2252509T3 ES 2252509 T3 ES2252509 T3 ES 2252509T3 ES 02767427 T ES02767427 T ES 02767427T ES 02767427 T ES02767427 T ES 02767427T ES 2252509 T3 ES2252509 T3 ES 2252509T3
Authority
ES
Spain
Prior art keywords
compound
phenyl
disease
formula
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02767427T
Other languages
English (en)
Spanish (es)
Inventor
David Michael Goldstein
David Mark Rotstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2252509T3 publication Critical patent/ES2252509T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES02767427T 2001-08-30 2002-08-26 Compuestos de aminopirrol como agentes antiinflamatorios. Expired - Lifetime ES2252509T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
US316169P 2001-08-30

Publications (1)

Publication Number Publication Date
ES2252509T3 true ES2252509T3 (es) 2006-05-16

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02767427T Expired - Lifetime ES2252509T3 (es) 2001-08-30 2002-08-26 Compuestos de aminopirrol como agentes antiinflamatorios.

Country Status (16)

Country Link
US (1) US6696471B2 (enExample)
EP (1) EP1423378B1 (enExample)
JP (1) JP2005506324A (enExample)
KR (1) KR20040029075A (enExample)
CN (1) CN1281603C (enExample)
AR (1) AR037140A1 (enExample)
AT (1) ATE309239T1 (enExample)
AU (1) AU2002331179B2 (enExample)
BR (1) BR0212077A (enExample)
CA (1) CA2458808A1 (enExample)
DE (1) DE60207273T2 (enExample)
ES (1) ES2252509T3 (enExample)
MX (1) MXPA04001810A (enExample)
PL (1) PL373115A1 (enExample)
RU (1) RU2315045C2 (enExample)
WO (1) WO2003020715A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
WO2006020365A2 (en) * 2004-07-26 2006-02-23 The Regents Of The University Of California Method for prevention or treatment of inflamatory disease
US20100104536A1 (en) * 2007-03-20 2010-04-29 Indravadan Ambalal Modi P38 inhibitors
WO2017075274A1 (en) 2015-10-27 2017-05-04 Children's Hospital Medical Center Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
CA3127373A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
AU3044197A (en) 1996-07-11 1998-02-09 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
KR100404256B1 (ko) 1998-05-05 2003-11-01 에프. 호프만-라 로슈 아게 피-38 엠에이피 키나제 저해제로서의 피라졸 유도체
CA2331878A1 (en) * 1998-05-14 1999-11-18 G.D. Searle & Co. 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
WO2003020715A1 (en) 2003-03-13
JP2005506324A (ja) 2005-03-03
CN1547578A (zh) 2004-11-17
PL373115A1 (en) 2005-08-08
EP1423378B1 (en) 2005-11-09
DE60207273D1 (de) 2005-12-15
CA2458808A1 (en) 2003-03-13
EP1423378A1 (en) 2004-06-02
KR20040029075A (ko) 2004-04-03
RU2004109817A (ru) 2005-10-20
AU2002331179B2 (en) 2008-04-17
MXPA04001810A (es) 2004-07-08
ATE309239T1 (de) 2005-11-15
AR037140A1 (es) 2004-10-27
CN1281603C (zh) 2006-10-25
US6696471B2 (en) 2004-02-24
RU2315045C2 (ru) 2008-01-20
DE60207273T2 (de) 2006-07-20
US20030130319A1 (en) 2003-07-10
BR0212077A (pt) 2004-09-28

Similar Documents

Publication Publication Date Title
JP3775796B2 (ja) 抗炎症活性及び/又は鎮痛活性を有する硝酸エステル類及びそれらの製造方法
FI88504C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat
PT91580B (pt) Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos
CN101143845A (zh) 取代喹啉甲酰胍衍生物、其制备方法及其医药用途
JP2006516653A (ja) キナーゼ阻害剤ピロロトリアジンの製造方法
ES2252509T3 (es) Compuestos de aminopirrol como agentes antiinflamatorios.
JPH0413340B2 (enExample)
PL119501B1 (en) Process for manufacturing novel,condensed pyrimidine derivatives pirimidina
ES2562903T3 (es) Nuevo compuesto que tiene actividad inhibidora de PARP
ES2204171T3 (es) Derivados de furopiridina y su utilizacion terapeutica.
AU2002331179A1 (en) Aminopyrrole compounds as antiinflammatory agents
Hall et al. Quinoline derivatives as antiallergy agents. 2. Fused-ring quinaldic acids
KR880001719B1 (ko) 1,4,9,10-테트라하이드로-피라졸로[4,3-e]-피리도[3,2-b][1,4]디아제핀-10-온의 제조 방법
JPH0251914B2 (enExample)
CN118388430A (zh) 紫檀芪查尔酮类化合物、其制法及医药用途
WO2021038540A1 (en) Cycloalkylidene carboxylic acids and derivatives as btk inhibitors
PT92000B (pt) Processo para a preparacao de prodrogas de 3-acil-2-oxindole-1-carboxamidas anti- inflamatorias
JPS6345387B2 (enExample)
JPS6229585A (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置2で置換された4―ohキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
JPS5840544B2 (ja) 1−(2−(b− ナフチルオキシ )−エチル)−3− メチル − ピラゾロン −(5) ノセイゾウホウホウ
JPH0625191B2 (ja) 1−[2−(フエニルメチル)フエニルピペラジン化合物、その製造方法および医薬組成物
SU1235867A1 (ru) 2-(0-Карбоксифениламино)-6 @ -пиримидо (2,1- @ )хиназолон-6 сол нокислый,про вл ющий противовоспалительную активность
HU198296B (en) Process for producing new 2-pyridyl acetic acid derivatives and pharmaceutical compositions comprising same
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
US20250051314A1 (en) Small molecule inhibitors of interferon gamma signaling